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Abstract
Background: With the introduction of tissue microarrays (TMAs) researchers can investigate
gene and protein expression in tissues on a high-throughput scale. TMAs generate a wealth of data
calling for extended, high level data management. Enhanced data analysis and systematic data
management are required for traceability and reproducibility of experiments and provision of
results in a timely and reliable fashion. Robust and scalable applications have to be utilized, which
allow secure data access, manipulation and evaluation for researchers from different laboratories.
Results: TAMEE (Tissue Array Management and Evaluation Environment) is a web-based database
application for the management and analysis of data resulting from the production and application
of TMAs. It facilitates storage of production and experimental parameters, of images generated
throughout the TMA workflow, and of results from core evaluation. Database content consistency
is achieved using structured classifications of parameters. This allows the extraction of high quality
results for subsequent biologically-relevant data analyses. Tissue cores in the images of stained
tissue sections are automatically located and extracted and can be evaluated using a set of
predefined analysis algorithms. Additional evaluation algorithms can be easily integrated into the
application via a plug-in interface. Downstream analysis of results is facilitated via a flexible query
generator.
Conclusion: We have developed an integrated system tailored to the specific needs of research
projects using high density TMAs. It covers the complete workflow of TMA production,
experimental use and subsequent analysis. The system is freely available for academic and non-
profit institutions from http://genome.tugraz.at/Software/TAMEE.
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Tissue microarray (TMA) technology is a high-throughput
tool for simultaneous analysis of up to 1000 different tis-
sue samples at the DNA, RNA or protein level in a single
experiment. TMA technology evolved from different pre-
cursors [1-5] to a form described by Kononen et al. [6] and
includes numerous varieties [7-10]. TMAs as proposed by
Kononen consist of a paraffin block (array or recipient
block) into which cylindrical tissue cores extracted from
different formalin-fixed paraffin-embedded (FFPE) tissue
samples (donor blocks) are inserted in an array. From a
single array block up to 200 sections can be made and
analyzed by immunohistochemistry (IHC), in situ hybrid-
ization (ISH), or immunofluorescence (IF).
Compared to conventional pathology analyses where sin-
gle tissue specimens are investigated individually, TMAs
provide results from large numbers of different tissue
samples in a single experiment. The major advantage is
that the experimental conditions for all samples are equal
and the amounts of consumables required are markedly
reduced. TMAs also preserve precious raw material
(archived tissue samples) since a single donor block can
provide cores for multiple arrays [11,12].
The TMA workflow comprises the following steps: (i)
design of the TMA and selection of tissue samples, (ii)
production of the array block, (iii) sectioning of the block
and quality control of the sections, (iv) molecular analysis
of TMA sections, (v) image acquisition, (vi) evaluation of
core images, and (vii) statistical analysis of the results.
These steps produce a significant amount of data that
must be stored in a centralized repository to give all
researchers involved in a TMA-based study access to the
relevant information. Special emphasis has to be directed
to the standardization of the entered data through the use
of existing ontologies and classifications to enable mean-
ingful down-stream analysis. Sample scoring has now
become the major bottleneck since instead of a small
number of stained whole biopsy sections, hundreds of
cores must be evaluated in a reproducible and timely
manner.
The power of the TMA technology has led to a rapid
increase in the number of labs adopting the technology
and an explosion of generated data. Managing and
extracting valuable information from such data requires
new and efficient data management platforms and com-
putational approaches. Numerous efforts have been
undertaken to develop software tools to handle different
aspects of the TMA workflow. However, to the best of our
knowledge, there is currently no academic data manage-
ment platform supporting the complete TMA pipeline.
Among existing applications spreadsheet based systems
[13-16] have been suggested as well as applications con-
centrating on web based manual core evaluation [17-20]
and applications with a wider range of workflow compo-
nents [21-27]. The applications of Chen et al. [28,29] and
Rabinovich et al. [30] focus mainly on the image acquisi-
tion step. Only Vrolijk et al. [15] and Demichelis et al. [25]
provide systems that contain a component for automatic
core localization and extraction of core images (see Table
S1 in Additional file 1 for comparison of features of cur-
rently published systems).
One of the most important steps in the TMA workflow –
the evaluation of core images – has been addressed in a
single database application [25]. The results of the evalu-
ation are the basis for the downstream analysis, where
biological markers are correlated with outcome and prog-
nosis or used to determine therapeutic measures. Manual
evaluation has been shown to be prone to significant
inter- and intra observer variability, especially for border-
line cases and with less experienced clinicians [31]. Auto-
mated image analysis promises to reduce evaluation
variability [31] and to reveal novel findings, not detected
by traditional pathologist-based scoring [32]. Different
(semi)-automated evaluation algorithms have been
described for IHC [15,29,30,33-35], IF [30,32,36,37] and
for ISH experiments [38]. Only the algorithm from
Dell'Anna et al. [35] is integrated into a web-based TMA
data management application [25].
Given the main shortcomings in the area of quality con-
trol, image acquisition and automated core analysis
sparked us to develop TAMEE, a web-based database
application using state of the art software technology,
ensuring extensibility, scalability, maintainability and
portability. It supports the complete TMA workflow, com-
prising the following features:
• Management of data related to tissues and donor blocks
• Storage of TMA design and array block data
• Tracking of array block sectioning and section quality
control
• Automated gridding of the TMA slide images and extrac-
tion of core images
• Automated evaluation of core images and flexible stor-
age of evaluation results
• Plug-in framework for the integration of additional eval-
uation algorithms
• Support for standardized and consistent database con-
tent with controlled vocabulariesPage 2 of 12
(page number not for citation purposes)
BMC Bioinformatics 2007, 8:81 http://www.biomedcentral.com/1471-2105/8/81• Compatibility with data interchange standards
• Operating system and browser independence
Implementation
System architecture
The TMA data management application was implemented
using Java, an object-oriented and platform independent
programming language [39]. The application is three
tiered, consisting of the database tier, the application
server tier and the client tier. The open source database
MySQL [40] is used as the data-base backend and the
business logic is implemented using Enterprise Java Beans
(EJBs) [41]. The runtime environment for the EJBs is pro-
vided by JBoss, a J2EE compatible application server [42].
The presentation layer is implemented using the Model-
View-Controller (MVC) framework Struts [43]. Features
requiring complex, immediate response on user input are
implemented as Java Applets [44].
Integration of algorithms evaluating core images is facili-
tated by a plug-in framework in a flexible and extendable
way. The framework consists of the following compo-
nents: (i) an abstract algorithm bean, which defines the
methods to be implemented and provides convenience
functions which can be utilized by the derived algorithms,
(ii) a flexible database model to manage the available
algorithms and to store the image evaluation results (see
below), and (iii) a web interface to hot-deploy newly cre-
ated algorithms and to manage existing ones. A descrip-
tion of the framework and Java source code for a sample
algorithm is provided as Additional file 2. It can be used
as the basis for the development of additional algorithms.
Commercial algorithms can be integrated by implement-
ing a "wrapper" algorithm, provided a command line ver-
sion of the commercial algorithm exists.
The complete application has been designed using UML
[45]. The UML representation improves maintainability
as the application architecture is immediately visible and
the components can be easily identified. The UML model
is the basis for code generation with the AndroMDA
framework [46], which relieves the developer from tedi-
ous and repetitive coding task and allows him to concen-
trate on the business logic and presentation part of the
implementation. The UML model is available as Addi-
tional file 3.
Database schema
The database schema supports the complete TMA work-
flow (see Additional file 4). TMA design and construction
is covered by the "Tissues", "Donor" and "Arrayblock"
tables. The tissue tables are accompanied by the tables
storing the ICD-O diagnosis coding and the TNM staging
definitions in the data dictionary. Additionally de-identi-
fied sample identification is stored, which provides a link
to both sensitive and insensitive patient data in the clini-
cal database. The array layout including the array
attributes like core diameter and spacing is associated
with a constructed array block. The "Section" table stores
data related to a cut section like related array block, thick-
ness, section index within array block, and type of micro-
tome used. One or more section images (stained or
unstained) can be related to a section via the "SectionIm-
age" table. For stained sections, the staining protocol, the
antibody used and the related antigen are recorded. Each
core stored in the "Punch" table is associated to a specific
section, the corresponding array block and the related
donor. A list of available evaluation algorithms is located
in the "Algorithm" table; the evaluation results of core
images in the "PunchImage" table are stored in the
"Result" table.
A hybrid database schema has been designed consisting of
a conventional relational part for entities with a static
attribute set and a part implemented as an entity-
attribute-value (EAV) schema [47,48]. In the former, each
parameter is represented by a separate column in a data-
base table. The latter is used to support the highly
dynamic attribute set resulting from the manual and auto-
matic evaluation of core images. The entity is a certain
core image, which has been evaluated, the attribute is the
algorithm used for the evaluation of the core image and
the value is the result of the evaluation. A simplified EAV
approach is used, where all values are stored as strings
regardless of their actual data type. Using the EAV
approach to model the evaluation data, results from new,
currently not foreseen scoring algorithms can be accom-
modated in a generic way, without the necessity to update
the database schema.
Controlled vocabularies are stored on the one hand in the
ICD-O related tables ("Topography", "Morphology",
"Behaviour" and "Grade") and on the other hand in the
"Datadictionary" table.
All images are stored as binary large objects (BLOBs) in
the database using two formats, namely resolution
reduced, compressed JPEG for quick viewing and high res-
olution, lossless compressed TIFF for scoring and display
of image details.
Image acquisition and extraction of core images
Images of the HE stained donor block sections, which are
used to determine the positions where the cores are
extracted and the TMA sections used for quality control
are scanned with an Epson Perfection 1660 Photo flatbed
scanner (Epson, Meerbusch, Germany) with 16 μm per
pixel. IF-stained sections were digitized with a GMS-418Page 3 of 12
(page number not for citation purposes)
BMC Bioinformatics 2007, 8:81 http://www.biomedcentral.com/1471-2105/8/81laser scanner (Affymetrix, Santa Clara, CA, USA) at 10 μm
per pixel.
Extraction of core images is a three step process: (i) mark-
ing of corner cores position (ii) localization of cores in the
image, (iii) determination of core extents, and (iv) saving
of core images in the database. Prior the determination of
the core positions, color images are converted to gray-
scale, taking the different luminance contributions of the
colors into account. Corner core positions are marked
manually to be able to determine the overall array orien-
tation. After cropping, mirroring, and rotation of the
image based on the marked corner positions, the centers
of the cores are determined using the radon transform
[49]. Based on the array layout (the number of rows and
columns) the local minima in the radon transformed data
are used as the starting points for horizontal and vertical
lines. The crossings of the lines are regarded as approxi-
mate centers of the cores. A binary image is created based
on the gray-scale histogram and noise is removed by mor-
phological image operations. The previously determined
core centers are used as the seed for the subsequent border
tracing algorithm [50] to determine the exact extent of the
core in the image. Rectangular sub-images which cover the
complete core are extracted from the section image and all
pixels outside the cores extend are set to 0 before the
image is stored in the database.
Section quality control
After a section has been cut and transferred to the carrier
slide, it is scanned with a flatbed scanner to keep track of
the section quality. These quality control images are grid-
ded and the images of the cores extracted. For each core,
the nominal core area (calculated based on the core diam-
eter from the array layout) is compared to the actual area.
If the actual area is below (indicating loss of tissue) or
above (indicating overlapping or aggregation of cores) a
certain percentage of the nominal one, the core is flagged
as bad. Additionally, cores whose shape significantly devi-
ates from circularity are marked.
Analysis of multiple IF stained cores
Double stained sections using antibodies labeled with dif-
ferent fluorophores (e.g. Cy3 and Cy5) are scanned with a
laser scanner, which creates two grayscale images, one for
each fluorophore [37]. A merged image is gridded and the
core images are extracted from both original images as
described above. The individual core images are evaluated
with respect to the following parameters: median core
intensity, integral of core intensity and percentage of core
area stained. Additionally, the ratio of the median intensi-
ties of the two fluorophores, the percentage to which the
stained areas of the two fluorophores overlap, and the
median intensity of one fluorophore in the area which is
stained by the other are calculated. The evaluation results
are stored in the database, where they are available for fur-
ther analysis.
Results and discussion
TAMEE is a system which covers all steps in the TMA
workflow, starting with the design of a TMA and spanning
to the automated analysis of core images. It accommo-
dates the requirements of different tissue types and of cur-
rent and future image evaluation algorithms. The web-
based application uses J2EE application server technology
providing industry grade stability, scalability, and extensi-
bility.
Tissue microarray design
Prior to the production of a TMA, tissues appropriate for a
given TMA design are selected by querying the clinical
database which contains information regarding cases and
associated donor blocks. Basic tissue information (like
diagnosis and unique sample identification) is exported
from the clinical database in tabular form. This table is
amended with the bar-code identifier of the donor block
and specific comments about core selection and location.
The sample data related to an array is uploaded into the
database and joined after array production with the layout
information. Alternatively, tissue and donor block infor-
mation can be entered manually if needed. Images of
donor block sections stained with Hematoxylin and Eosin
(HE), used to identify a representative core position
within the specimen, are also stored in the database for
quality control and tracking purposes (Figure 1).
Production and quality control
Array blocks are produced with a custom-built robotic
TMA Arrayer (Oridis-Biomed GmbH, Graz, Austria),
based on the selected position of a core on the donor
block and the target location for the core in the array
block. Each array block is also identified by a unique bar-
code. During array production, the robot control software
produces an array description file in tabular form, includ-
ing the donor block barcode, core location on the donor
block, and row and column of the core in the TMA. This
file is uploaded into the database and associated to the
corresponding donor blocks and to one of several existing
array layouts possible with the arrayer. Currently four lay-
outs encompassing 240 to 487 cores are available (Figure
2). Additional array layouts can be defined via the web
interface.
Sections created from the TMA block are recorded in the
database together with related information like section
thickness, type of microtome used, and corresponding
depth in the TMA block. Generally, sections are created in
batches; this is accounted for in the section entry screen,
where section parameters of a batch including the number
of sections are defined (Figure 3). To track the quality ofPage 4 of 12
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resolution image of the unstained slide. These images are
stored in the database and quality scores that include, for
example, core completeness and core shape are assigned
via an evaluation algorithm.
Molecular section analysis
TMA sections are useful for a range of molecular analyses
that can also be performed on regular tissue sections, such
as IHC, ISH, or IF. For every analysis the subject of the
analysis (antigen, DNA or RNA sequence) and the experi-
mental conditions are recorded. Type and concentration
of antibodies utilized in an IHC or IF analysis are added
as an experimental parameter. To ensure reproducibility,
the experimental protocol is associated in TAMEE as a
PDF file for reference during data evaluation. Digital
images of the stained section, obtained either via photom-
icroscopy or from a laser scanner, are related to the analy-
sis parameters and stored for later core image extraction
and analysis. In general one grayscale or color image is
available from an experiment, in the case of IF experi-
ments with multiple antigens investigated, two grayscale
images are created for joint evaluation [37].
Extraction and evaluation of core images
Images of a complete TMA section are uploaded into the
database. During core image extraction the individual
cores are automatically located (Figure 4) and a square
image area with the core in its center is stored for later
analysis. Extraction from both HE or IHC stained images
(with a white background) and IF images (with a black
background) is supported. Pixels not belonging to the
core (either background or artifact) are set to zero to pro-
vide a standardized basis for core analysis. Gridding and
HE stained section of a donor blockFigure 1
HE stained section of a donor block. The section is used to identify areas of interest in the donor block for extraction of 
cores to place in the array block (identified by a pathologist with red or black ink). The positions where cores have been 
extracted are marked with black circles. Moving the mouse over a core position displays detailed information about the related 
array block, the position of the core on the array block and the index of the core on the donor block.
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is accomplished within 35 seconds on an Intel Pentium M
system at 1.6 GHz and 1 GB of RAM.
Cores originating from the quality control section images
are evaluated for area and shape (roundness). Cores that
fall within certain area and roundness ranges are consid-
ered acceptable for evaluation in later experimental anal-
ysis. If a section shows too many cores outside the
acceptable range, the section is abandoned.
IF experiments allow the concurrent investigation of mul-
tiple antigens using different fluorophores attached to the
antibodies to determine, for example, colocalization of a
tumor marker with a cell type specific marker. For each
fluorophore, a grayscale image is created, from which the
area stained by the antibody is determined. Additionally,
the area of overlap of staining with the different antibod-
ies is calculated. This allows normalization of the results
and semi-quantitative analysis of the cores [37].
For each run of an analysis algorithm, evaluation results
are written to the database together with the evaluation
results, date and time of the run and a reference to the user
who invoked the analysis. There is no restriction on the
type of evaluation results, categorical data as well as con-
tinuous data is supported. The analysis algorithms are
embedded in a plug-in framework, which allows the inte-
gration and use of additional algorithms without requir-
ing adaptations in other parts of the application (see
Layout of a TMA with 487 coresFigure 2
Layout of a TMA with 487 cores. The individual cores of the array are colored according to the topographic origin of the 
tissue sample. Moving the mouse over a core displays detailed information about the core: topography, morphology, classifica-
tion, grade (according to ICD-O) and the barcode of the donor block.
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sample algorithm). These additional analysis algorithms
can either be newly developed academic ones or existing
commercial ones like AQUA [51] or SpotBrowser [52].
Automated core analysis provides several advantages over
manual scoring which is affected by intra- and inter-
observer variability and allows assignment of categorical
scores only. Automated image analysis improves the
reproducibility of the evaluation results [31,53] and pro-
vides a solid basis for subsequent analysis of the prognos-
tic value of a certain marker [54]. Furthermore, scoring is
carried out on a continuous scale, which allows the anal-
ysis to be performed without stratification. This increases
the statistical power of the analysis and avoids the intro-
duction of a bias [55,56].
Controlled vocabularies
User input for the same entity can be very heterogeneous,
depending on educational background, personal prefer-
ences and a host of other variables. Non-standardized
data is almost impossible to query and therefore dimin-
ishes the value of the database. Hence TAMEE uses –
wherever possible and reasonable – existing public classi-
fications and self-defined data dictionaries to ensure
standardized and consistent data entry. Disease diagnoses
are encoded using ICD-O (International Classification of
Diseases for Oncology) [57] and the TNM classification
scheme [58] is used for the tumor status. Custom data dic-
tionaries have been created for TMA parameters including
tissue source, type of paraffin utilized, microtome model
used during sectioning, and section storage conditions.
The data dictionaries are user extendable, which allows
TAMEE sample input screenFigure 3
TAMEE sample input screen. Fields where input is required are marked magenta, optional fields are colored blue. Drop-
down list boxes for the selection of appropriate attribute values are used extensively to ensure standardized and consistent 
database content.
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tation of the application itself.
Data entry and query
A consistent and clear application interface is provided for
users with primarily a medical or biological background.
Screens can be divided into two major groups: (i) entry
screens for primary data entry, and (ii) list views for the
compact display of available entities. Entry screens consist
of mandatory fields – colored magenta- and optional
fields in blue (Figure 3). Drop down selection lists are
used extensively to ensure standardized data entry. Free
text can be entered in fields not used in subsequent anal-
ysis queries. Data entered is checked for validity and in the
case of an erroneous entry the user is informed appropri-
ately. List view screens present the entities in tabular form
and allow paging, querying and the selection of which
entity attributes are displayed (Figure 5). Queries can be
performed on any combination of the available attributes
using a standard set of query operators. After the query is
submitted, the displayed list is narrowed to the matching
entries of the specified query.
Data access control
Although TAMEE manages de-identified patient data
only, access to and modification of the information has to
be tightly controlled. Therefore, access to the web applica-
tion is secured by an authentication and authorization
system as described previously [59]. It manages user
account information, assignment of users to certain appli-
cation roles and application resources together with their
associated access control lists. By default, TAMEE utilizes
three application roles, namely "Administrator", "User",
and "Guest". Guest users are granted read only access to
all entities. The more privileged User role allows perform-
ance of all operations related to the routine TMA work-
flow. Administrators are enabled to perform management
tasks like altering and extending the data dictionary and
the definition of array block layouts. Additionally, the
right to delete data in the database is granted to adminis-
trative users only. The access rules for these groups can be
changed according to different requirements and addi-
tional groups with special entity access patterns can be
defined using the authentication and authorization sys-
tem.
Support for data exchange specifications
To allow sharing of experimental data in a reproducible
and complete form, data interchange standards are
becoming increasingly important [60,61]. To this end, the
Association for Pathology Informatics proposed the "Tis-
sue Microarray Data Exchange Specification" (TMA-DES)
[62-64]. TAMEE can export TMA analysis data in the for-
mat proposed in TMA-DES and allows the dissemination
of supplemental experimental data related to a publica-
tion and the submission of parameters and results to pub-
lic data repositories in a standardized format. Recently,
the "MISFISHIE" standard [65] covering IHC and ISH
experiments has been described and TMA-OM [27], an
object model for TMA data accompanied by a correspond-
ing XML representation has been suggested. As these data
representations gain acceptance, support for them can be
added to TAMEE as well.
Stained and gridded TMA sectionFigure 4
Stained and gridded TMA section. (a) TMA section with 
about 480 tissue cores from different cancer tissue samples. 
Cytokeratin has been detected by IHC (brown areas) using a 
cytokeratin antibody (mouse anti human; DAKO; M3515) 
and the EnVision detection Kit (DAKO, K4065). Tissue cores 
are made visible with a Hematoxilin counterstain (light blue). 
(b) The same section after automatic core localization and 
shape determination. The outline of a core is displayed in 
blue. Positions with missing cores (), cores which are too 
large (more than 160% of the expected area, ) and cores 
which are too small (less than 40% of the expected area, ) 
are shown in red. Array positions without a symbol or out-
line have been deliberately left empty during TMA produc-
tion. Gridding ambiguities in heavily distorted areas of the 
array are corrected manually.
a) 
b) 
?Page 8 of 12
(page number not for citation purposes)
BMC Bioinformatics 2007, 8:81 http://www.biomedcentral.com/1471-2105/8/81Conclusion
We have developed TAMEE, a portable, web-based data-
base application using state of the art application server
and database technology tailored to the specific needs of
research projects using high density tissue microarrays.
The system covers the complete TMA workflow and man-
ages significant amounts of data accumulating during the
production and application of TMAs. It allows simultane-
ous access and update of data as required in multicenter
studies. TAMEE facilitates the traceability of all steps dur-
ing the production and the molecular analyses of TMA
sections by collecting the relevant laboratory and quality
parameters. Additionally, TMA data can be exported in the
standardized TMA-DES format for sharing and dissemina-
tion of TMA design, experimental conditions, and evalua-
tion results. Key features are quality control in TMA
production and molecular analysis, standardized data
entry using controlled vocabularies, and the plug-in
framework for the integration of automated core image
evaluation algorithms.
Availability and requirements
• Project name: TAMEE
• Project home page: http://genome.tugraz.at/Software/
TAMEE
• Operating system: Solaris, Linux, Windows, Mac OS X
• Programming language: Java, HTML
• Other requirements: Java JDK 1.5.x, MySQL 4.0.x with
InnoDB engine, a server with at least 1 GBytes of main
memory available to the application
• License: None required
Sample TAMEE list viewFigur  5
Sample TAMEE list view. A selection of donor blocks based on their barcodes is shown. The list view consists of 1) the 
query parameters, 2) the customizable display settings and 3) the list itself. Areas 1) and 2) are hidden by default and are made 
visible by clicking at the respective icons in the header.
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Installation of the application is straight-forward and
should be manageable within a few hours provided the
necessary MySQL access rights are granted. Step-by-step
instructions are provided at the projects Web site together
with the files and scripts necessary for installation. The ref-
erence installation of TAMEE is running on a Sun V20z
Opteron server (Sun Microsystems Ges.m.b.H, Vienna,
Austria) with 8 GB of memory under CentOS Linux [66]
using MySQL [40] as database management system.
Attached is a Storage Area Network (EVA 5000, Hewlett-
Packard Ges.m.b.H., Vienna, Austria) with 5.5 TBytes.
The production instance of TAMEE is hosted on a HP Pro-
liant ML350G4P (Hewlett-Packard Ges.m.b.H., Vienna,
Austria) under Windows 2003 Server with 2 GB of main
memory and an 800 GB RAID-5 storage.
List of abbreviations
BLOB Binary Large Object
EAV Entity Attribute Value
FFPE Formalin fixed, paraffin embedded
ICD-O International Classification of Diseases for Oncol-
ogy
HE Hematoxilin and Eosin
IF ImmunoFluorescence
IHC ImmunoHistoChemistry
ISH In Situ Hybridization
J2EE Java 2 Enterprise Edition
JPEG Joint Photography Expert Group
TMA-DES Tissue MicroArray Data Exchange Specification
TIFF Tagged Image File Format
TNM Tumor, Nodes, Metastasis (tumor classification sys-
tem of the Union against Cancer)
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